Post-effective amendment to a registration statement that is not immediately effective upon filing

Fair Value Measurements (Tables)

v3.23.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value, assets and liabilities measured on recurring basis
 

Level 1

 

Level 2

 

Level 3

 

Total

As of December 31, 2022

 

 

   

 

   

 

   

 

 

Assets:

 

 

   

 

   

 

   

 

 

Investment – Cansativa

 

 

 

 

 

 

5,679

 

 

5,679

Total Assets

 

$

 

$

 

$

5,679

 

$

5,679

Liabilities:

 

 

   

 

   

 

   

 

 

Loans and borrowings

 

 

 

 

1,530

 

 

 

 

1,530

Warrant liability

 

 

 

 

 

 

113

 

 

113

Total Liabilities

 

$

 

$

1,530

 

$

113

 

$

1,643

   

 

   

 

   

 

   

 

 

As of December 31, 2021

 

 

   

 

   

 

   

 

 

Assets:

 

 

   

 

   

 

   

 

 

Investment – Cansativa

 

 

 

 

 

 

1,458

 

 

1,458

Total Assets

 

$

 

$

 

$

1,458

 

$

1,458

Liabilities:

 

 

   

 

   

 

   

 

 

Loans and borrowings

 

$

 

$

7,396

 

$

 

$

7,396

Warrant Liability

 

 

 

 

 

 

2,205

 

$

2,205

Convertible notes

 

 

 

 

17,699

 

 

 

 

17,699

Total Liabilities

 

$

 

$

25,095

 

$

2,205

 

$

27,300

Schedule of summary of changes in fair value of the Company’s Level 3 investments
 

Level 3

Balance, December 31, 2021 (Measured at equity method)

 

$

1,458

 

Share of Equity investment loss

 

$

(64

)

Partial sale on investments

 

$

(515

)

Gain due to change in fair value included in earnings

 

$

4,868

 

Change in value due to foreign exchange loss

 

$

(68

)

Balance, December 31, 2022

 

$

5,679

 

Schedule of change in fair value of warrant liabilities related to private warrants

Private Placement Warrants:

 

Total Warrant
Liability

Warrant liability at December 31, 2021

 

$

2,205

 

Change in fair value of warrant liability

 

 

(2,092

)

Warrant liability at December 31, 2022

 

$

113

 

Schedule of the fair value of its private warrants using the Monte Carlo simulation model
 

As of

   

December 31,
2022

 

December 31,
2021

Risk-free interest rate

 

 

4.23

%

 

 

1.11

%

Expected volatility

 

 

105

%

 

 

60

%

Share Price

 

$

0.31

 

 

$

3.10

 

Exercise Price

 

$

11.50

 

 

$

11.50

 

Expiration date

 

 

December 18, 2025

 

 

 

December 18, 2025